Incidence of community onset MRSA in Australia: least reported where it is Most prevalent

Antimicrobial Resistance and Infection Control
Jessica K CameronKate Halton

Abstract

This is the first review of literature and synthesis of data on community onset methicillin resistant Staphylococcus aureus (CO-MRSA) infections in Australia. Incidence of CO-MRSA varies considerably in Australia, depending on geographic and demographic factors. Data for the rates of MRSA infections were collected from articles identified using PubMed, Scopus, the grey literature and data from State and Federal Government Surveillance Systems. We synthesized data and developed a framework for how data was selected, collated, linked, organized and interpreted. The results of our literature search demonstrates considerable gaps in the reporting of CO-MRSA in Australia. Consequently, total incidences were under reported; however the available data suggests the incidence varied between 44 (Tasmania) and 388 (southern Northern Territory) cases per 100,000 person years. Hospitalised cases of CO-MRSA varied between 3.8 (regional Victoria) and 329 (southern Northern Territory). Taking the median percentage of infections by site for all regions available, skin and soft tissue infections (SSTIs) consisted of 56% of hospitalized CO-MRSA, compared with bacteremias, which represented 14%. No region had a complete data set of CO-MRSA infecti...Continue Reading

References

Dec 10, 1998·Journal of Internal Medicine·L LeiboviciS D Pitlik
May 27, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Thomas P LodiseMichael J Rybak
Jul 2, 2004·Tropical Medicine & International Health : TM & IH·Mark W DouglasBart J Currie
Nov 29, 2005·The Lancet Infectious Diseases·Heiman F L WertheimJan L Nouwen
Mar 1, 2006·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·R KhatibL B Johnson
Oct 13, 2006·BMC Family Practice·Lisa H AmirJudith Lumley
Dec 8, 2007·American Journal of Infection Control·Noleen J BennettMichael J Richards
Feb 19, 2008·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·W J MunckhofP Giffard
Mar 18, 2008·International Journal of Antimicrobial Agents·Graeme R Nimmo, Geoffrey W Coombs
Oct 14, 2008·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·J O RobinsonR J Murray
Jan 22, 2009·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·W J MunckhofP Giffard
Oct 8, 2009·The Medical Journal of Australia·John D TurnidgeUNKNOWN Australia New Zealand Cooperative on Outcomes in Staphylococcal Sepsis
Jun 16, 2010·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·M C WehrhahnR J Murray
Jun 22, 2010·Internal Medicine Journal·M G W RémondG P Maguire
Aug 12, 2010·JAMA : the Journal of the American Medical Association·Alexander J KallenUNKNOWN Active Bacterial Core surveillance (ABCs) MRSA Investigators of the Emerging Infections Program
Dec 15, 2010·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Kyra ChuaBenjamin P Howden
Mar 9, 2011·Respirology : Official Journal of the Asian Pacific Society of Respirology·Rajesh ThomasPeter G Gibson
Mar 24, 2011·Clinical & Experimental Optometry : Journal of the Australian Optometrical Association·Patricia M Kiely, Joseph Chakman
May 23, 2012·Emerging Infectious Diseases·Gabrielle JonesFrédéric Barbut
May 24, 2012·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·K B LauplandUNKNOWN International Bacteremia Surveillance Collaborative
Oct 10, 2012·BMC Infectious Diseases·Steven Y C TongUNKNOWN Australian New Zealand Cooperative on Outcomes in Staphylococcal Sepsis
Feb 8, 2013·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·John MarquessArchie C A Clements
Apr 12, 2013·The Australian and New Zealand Journal of Psychiatry·Kim M Kiely, Peter Butterworth
Jun 4, 2014·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·D A WilliamsonG R Nimmo
Aug 11, 2015·The Australian Journal of Rural Health·Hilary L MartinMuhammad Adnan Khattak
Dec 2, 2015·Journal of the Pediatric Infectious Diseases Society·Daniel EngelmanSteven Y C Tong
Nov 3, 2017·The Medical Journal of Australia·Jason W AgostinoMartyn D Kirk
Aug 20, 2019·Scientific Data·Kristopher M FairMikhail Prokopenko

❮ Previous
Next ❯

Citations

Jun 15, 2021·Antimicrobial Agents and Chemotherapy·Isabel GuthridgeJosh Hanson
Jul 15, 2021·Antimicrobial Resistance and Infection Control·Jun Wern YauChris Rissel

❮ Previous
Next ❯

Software Mentioned

Scopus

Related Concepts

Related Feeds

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.